Feedback / Questions
Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
nanatinostat (VRx-3996) - Viracta Therap
https://www.globenewswire.com/news-release/2023/05/08/2663844/0/en/Viracta-Therapeutics-Reports-First-Quarter-2023-Financial-Results-and-Provides-Clinical-Program-Updates.html
May 8, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next